These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36422555)

  • 1. Recent Synthesis, Characterization, and Pharmacological Evaluation of Multifunctional Hemorphins Containing Non-Natural Amino Acids with Potential Biological Importance.
    Todorov P; Georgieva S; Tchekalarova J
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
    Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorphins-From Discovery to Functions and Pharmacology.
    Mielczarek P; Hartman K; Drabik A; Hung HY; Huang EY; Gibula-Tarlowska E; Kotlinska JH; Silberring J
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34201982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
    Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
    Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LVV- and VV-hemorphins: comparative levels in rat tissues.
    Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
    FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
    Fruitier I; Garreau I; Piot JM
    Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid peptides derived from hemoglobin: hemorphins.
    Zhao Q; Garreau I; Sannier F; Piot JM
    Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
    Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
    Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intraerythrocytic proteasome retards the generation of hemorphins.
    Song CZ; Wang QW; Liu H; Song CC
    Peptides; 2012 Jan; 33(1):170-3. PubMed ID: 22154669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of the therapeutic properties of hemorphins.
    Ali A; Alzeyoudi SAR; Almutawa SA; Alnajjar AN; Vijayan R
    Pharmacol Res; 2020 Aug; 158():104855. PubMed ID: 32438036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
    Todorov P; Georgieva S; Peneva P; Tchekalarova J
    Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin.
    Nyberg F; Sanderson K; Glämsta EL
    Biopolymers; 1997; 43(2):147-56. PubMed ID: 9216251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
    Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
    Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New N- and C-modified RGD-hemorphins as potential biomedical application on Ti-surface materials: synthesis, characterization and antinociceptive activity.
    Georgieva S; Todorov P; Nikolov S; Dzhambazova E; Peneva P; Assenov B; Pechlivanova D
    Mol Divers; 2023 Feb; 27(1):263-280. PubMed ID: 35438429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S
    Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
    Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorphins Targeting G Protein-Coupled Receptors.
    Ayoub MA; Vijayan R
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33799973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of appearance of four hemorphins from bovine hemoglobin peptic hydrolysates by HPLC coupled with photodiode array detection.
    Zhao Q; Sannier F; Piot JM
    Biochim Biophys Acta; 1996 Jun; 1295(1):73-80. PubMed ID: 8679676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of peripheral inflammation by locally administered hemorphin-7.
    Sanderson K; Nyberg F; Khalil Z
    Inflamm Res; 1998 Feb; 47(2):49-55. PubMed ID: 9535541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7.
    Ali A; Palakkott A; Ashraf A; Al Zamel I; Baby B; Vijayan R; Ayoub MA
    Front Pharmacol; 2019; 10():1258. PubMed ID: 31708782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.